Price T Rowe Associates Inc Gsk PLC Transaction History

Price T Rowe Associates Inc

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$42.05 - $47.77 $14.5 Million - $16.4 Million	-343,661 Reduced 2.26%	14,843,717 $646 Million
Q1 2022 May 16, 2022	BUY	$40.23 - $47.74 $2.7 Million - $3.21 Million	67,179 Added 0.44%	15,187,378 $662 Million
Q4 2021 Feb 14, 2022	BUY	$38.88 - $45.31 $13.3 Million - $15.5 Million	342,081 Added 2.31%	15,120,199 $667 Million
Q3 2021 Nov 15, 2021	BUY	$38.79 - $43.16 $4.25 Million - $4.73 Million	109,503 Added 0.75%	14,778,118 $565 Million
Q2 2021 Aug 16, 2021	SELL	$36.52 - $41.46 $31.9 Million - $36.3 Million	-874,666 Reduced 5.63%	14,668,615 $584 Million
Q1 2021 May 17, 2021	SELL	$34.27 - $40.01 $34.6 Million - $40.4 Million	-1,008,836 Reduced 6.09%	15,543,281 $555 Million
Q4 2020 Feb 16, 2021	BUY	$34.07 - $39.94 $564 Million - $661 Million	16,552,117 New	16,552,117 $609 Million

176K

Ticker GSK
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,033,689,984
Market Cap $69.3B
Description
GSK plc, together with its subsidiaries, engages in the creation, discovery, development, manufacture, and marketing of pharmaceutical products, vaccines, over-the-counter medicines, and health-related consumer products in the United Kingdom, the United States, and internationally. It operates through four segments: Pharmaceuticals, Pharmaceutic...

Get notified when there are updates to the investment portfolio of Price T Rowe Associates Inc , based on Form 13F filings with the SEC.

Stay updated on Price T Rowe Associates Inc with notifications on news.